Group


36 results

Group

A year-long partnership with the ISPC

A year-long partnership with the ISPC This year, Ipsen is partnering with the Institut…

Group

Ipsen – Combined Shareholders’ Meeting of 27 May 2021

In the context of the Covid-19 epidemic and in accordance with emergency measures decided by…

Group

Ipsen announces the arrival of Gwenan White, EVP Communicati...

We are pleased to announce the arrival of Gwenan White as Executive Vice President, Communications…

CSR

Ipsen and the fight against corruption

Today is International Anti-Corruption Day. We are all aware that corruption has the potential to…

Event

Ipsen’s new strategic priorities unveiled at virtual Capital...

Today, Ipsen is hosting a virtual Capital Markets Day to launch our new Group strategy…

Group

Ipsen – Q3 2020 Sales Conference Call – Thursday, Octo...

David Loew, Chief Executive Officer, is pleased to host a conference call to discuss the…

Group

Ipsen announces sales growth over the first 9 months of 2020

Around the world, COVID-19 cases are on the rise again. Despite the challenges presented by…

Group

Ipsen announces the appointment of new EVP Business Developm...

We are pleased to announce that our Business Development team will be led by Philippe…

Group

Executive Leadership Team Announcement

We are pleased to announce the appointment of Bartek Bednarz, Executive Vice President Global Product…

Financial information

Ipsen announces 3.1% Group Sales Growth, reinstates 2020 gui...

We are pleased to announce a resilient financial performance for H1 2020, despite the…

Group

David Loew joins Ipsen as CEO

We are delighted to welcome David Loew as the new CEO of Ipsen. A seasoned…

© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved - 2021